This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Jun Guan - Innovator in Antigen Binding Proteins
Introduction
Jun Guan is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 2 patents to his name, Guan's work is focused on addressing critical medical challenges.
Latest Patents
One of Jun Guan's latest patents involves antigen binding proteins that are designed for treating CD96 mediated diseases. The present disclosure relates to compositions that can potentially revolutionize treatment methods for these conditions. His innovative approach highlights the importance of targeted therapies in modern medicine.
Career Highlights
Guan is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research and development efforts. His work at this prominent company underscores his commitment to improving healthcare through innovative solutions.
Collaborations
Jun Guan has collaborated with esteemed colleagues such as Yan Y Degenhardt and Kenneth William Hance. These partnerships reflect the collaborative spirit that is essential in the field of scientific research and innovation.
Conclusion
In summary, Jun Guan is a dedicated inventor whose work in antigen binding proteins holds promise for the treatment of various diseases. His contributions to biotechnology are noteworthy, and his ongoing research continues to inspire advancements in medical science.